IndiaMTF — home
Stock

Sun Pharmaceutical Industries — MTF Book

SUNPHARMA · Sun Pharmaceutical Industries Limited
Health Technology

Daily Margin Trading Facility book for Sun Pharmaceutical Industries across NSE and BSE, from 01 Aug 2017. All figures in ₹ crore, derived from exchange public disclosures.

What is Sun Pharmaceutical Industries’s MTF book?

Sun Pharmaceutical Industries Limited (SUNPHARMA) has ₹276 crore funded under Margin Trading Facility across NSE and BSE as of 26 Oct 2026 — 0.18% of India’s MTF book, ranking #124. Over 1M (the last 30 trading days) the funded value has fallen 1.6%, with the number of shares under margin down 0.7%.

Funded value
₹276 Cr
as of 26 Oct 2026
Rank in book
#124
2,143 days tracked
Share of book
0.18%
of the whole NSE + BSE book
Peak funded
₹2,156 Cr
on 03 Aug 2017
Largest single-day addition
+₹2,152 Cr
on 03 Aug 2017
Largest single-day unwind
−₹2,150 Cr
on 04 Aug 2017
Free-float market cap
₹1,97,554 Cr
full market cap ₹4,17,484 Cr · 47.3% free float · Large cap
MTF share of free float
0.13%
0.4× the median large cap · 0.2× the Health Technology median

Share of free float on margin, month by month

Shares under margin at each month-end as a share of free-float shares, using that month-end’s share count and the free-float filing public at the time. It counts shares, not value, so a price move does not move it by itself.

0.00%0.05%0.10%0.16%Feb 2024Oct 2026
View as table: share of free float on margin31 months
Month-end% of free float
26 Oct 20260.133%
30 Sep 20260.139%
31 Aug 20260.126%
31 Jul 20260.113%
30 Jun 20260.121%
29 May 20260.124%
30 Apr 20260.042%
30 Mar 20260.040%
27 Feb 20260.119%
30 Jan 20260.091%
31 Dec 20250.045%
28 Nov 20250.029%
31 Oct 20250.049%
30 Sep 20250.061%
29 Aug 20250.065%
31 Jul 20250.051%
30 Jun 20250.075%
30 May 20250.071%
30 Apr 20250.024%
28 Mar 20250.021%
28 Feb 20250.024%
31 Jan 20250.025%
27 Dec 2024†0.021%
29 Nov 20240.021%
31 Oct 20240.018%
26 Aug 2024†0.019%
25 Jul 2024†0.020%
28 Jun 20240.046%
31 May 20240.057%
30 Apr 20240.040%
01 Feb 2024†0.017%

† Not the month’s last trading day: the last day the stock was in the archive that month (before 11 Nov 2025 the archive kept only the 500 largest positions).

Dated events

NSE & BSE split

How SUNPHARMA’s funded book divides across the two exchanges, as of 26 Oct 2026.
NSE
NSE ₹271 Cr · 98.2%BSE ₹5 Cr · 1.8%

MTF vs Price

Margin-funded outstanding for SUNPHARMA in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹1,748.00
as of 23 Oct 2026
Price, 1M
−6.3%
adjusted for splits and bonuses
Delivery, 20-day avg
62.2%
of traded volume actually settled
Sessions to unwind
2
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1D−₹3−0.9%−0.9%
−13,818
+0.0%unwinding as it falls
10D−₹0−0.1%+0.3%
+4,155
−0.7%building as it falls
1M−₹4−1.6%−0.7%
−10,054
−6.3%unwinding as it falls
3M+₹54+24.3%+23.6%
+2,87,475
−9.9%building as it falls
6M+₹103+59.7%+46.5%
+4,77,477
+7.9%building into strength
1Y+₹183+197.8%+173.7%
+9,55,131
+2.9%building into strength

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where SUNPHARMA has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

SUNPHARMA — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
26 Oct 2026276−₹30.18%124
23 Oct 2026279−₹10.18%123
22 Oct 2026279−₹20.18%124
21 Oct 2026282−₹10.18%123
19 Oct 2026283+₹10.18%123
16 Oct 2026282+₹00.18%124
15 Oct 2026282−₹40.18%124
14 Oct 2026286+₹30.18%124
13 Oct 2026282+₹60.18%124
12 Oct 2026276−₹00.18%128
09 Oct 2026276−₹10.18%129
08 Oct 2026277+₹00.18%130
07 Oct 2026277+₹10.18%130
06 Oct 2026276−₹10.18%129
05 Oct 2026276−₹20.18%131
01 Oct 2026278−₹30.18%130
30 Sep 2026281+₹20.18%130
29 Sep 2026279+₹10.18%131
28 Sep 2026278−₹00.17%131
25 Sep 2026278−₹10.18%131
24 Sep 2026279+₹20.18%130
23 Sep 2026277−₹20.18%128
22 Sep 2026279+₹30.18%125
21 Sep 2026276−₹40.18%127
18 Sep 2026280+₹30.18%121
17 Sep 2026277−₹10.18%125
16 Sep 2026278−₹30.18%124
15 Sep 2026281+₹00.18%124
11 Sep 2026281+₹10.18%121
10 Sep 2026280—0.18%123

SUNPHARMA within Health Technology

Ranked #7 of 61 funded Health Technology stocks, carrying 4.2% of that sector’s margin book. Its 0.13% of free float on margin is 0.1× the sector median of 0.89%. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector% of free floatBook, 1M
5VIYASHViyash Scientific₹4216.4%7.34%−16.0%
6DIVISLABDivi's Laboratories₹3495.3%0.30%+34.8%
7SUNPHARMASun Pharmaceutical Industries₹2764.2%0.13%−1.6%
8NATCOPHARMNatco Pharma₹1722.6%1.78%−8.7%
9ACUTAASAcutaas Chemicals₹1682.5%0.99%+53.9%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.